Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalNet MarginReturn on AssetsReturn on EquityReturn on Sales

HUTCHMED (China) (HCM) Invested Capital (2016 - 2025)

HUTCHMED (China) has reported Invested Capital over the past 12 years, most recently at $1.3 billion for Q4 2025.

  • Quarterly Invested Capital rose 60.49% to $1.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Dec 2025, up 60.49% year-over-year, with the annual reading at $1.3 billion for FY2025, 60.49% up from the prior year.
  • Invested Capital was $1.3 billion for Q4 2025 at HUTCHMED (China), up from $795.2 million in the prior quarter.
  • Over five years, Invested Capital peaked at $1.3 billion in Q4 2025 and troughed at $639.0 million in Q4 2022.
  • The 5-year median for Invested Capital is $795.2 million (2024), against an average of $910.3 million.
  • Year-over-year, Invested Capital skyrocketed 105.34% in 2021 and then tumbled 40.08% in 2022.
  • A 5-year view of Invested Capital shows it stood at $1.1 billion in 2021, then tumbled by 40.08% to $639.0 million in 2022, then grew by 21.22% to $774.5 million in 2023, then increased by 2.67% to $795.2 million in 2024, then soared by 60.49% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for HCM's Invested Capital are $1.3 billion (Q4 2025), $795.2 million (Q4 2024), and $774.5 million (Q4 2023).